These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24481415)

  • 21. Serum proatrial natriuretic peptide concentrations during oral glucose-induced acute hyperinsulinemia in lean and obese men.
    Asferg CL; Nielsen SJ; Andersen UB; Linneberg A; Goetze JP; Jeppesen JL
    Peptides; 2019 Jan; 111():98-102. PubMed ID: 29524563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment.
    Schneider P; Buerger K; Teipel S; Uspenskaya O; Hartmann O; Hansson O; Minthon L; Rujescu D; Moeller HJ; Zetterberg H; Blennow K; Ernst A; Bergmann A; Hampel H
    Biol Psychiatry; 2011 Jul; 70(2):145-51. PubMed ID: 21457948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
    Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
    Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.
    Andersson B; Hall C
    J Card Fail; 2000 Sep; 6(3):208-13. PubMed ID: 10997746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome.
    Montaner J; García-Berrocoso T; Mendioroz M; Palacios M; Perea-Gainza M; Delgado P; Rosell A; Slevin M; Ribó M; Molina CA; Alvarez-Sabín J
    Cerebrovasc Dis; 2012; 34(3):240-5. PubMed ID: 23018289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
    Krüger S; Ewig S; Kunde J; Hartmann O; Suttorp N; Welte T;
    Thorax; 2010 Mar; 65(3):208-14. PubMed ID: 20335288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension.
    Khaleghi M; Al-Omari MA; Kondragunta V; Morgenthaler NG; Struck J; Bergmann A; Mosley TH; Kullo IJ
    Am J Cardiol; 2009 May; 103(9):1255-60. PubMed ID: 19406268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular biomarker midregional proatrial natriuretic peptide during and after preeclamptic pregnancies.
    Sugulle M; Herse F; Hering L; Mockel M; Dechend R; Staff AC
    Hypertension; 2012 Feb; 59(2):395-401. PubMed ID: 22184318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides.
    Eggers KM; Venge P; Lind L
    Clin Chim Acta; 2013 Apr; 419():62-6. PubMed ID: 23415698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia.
    Seligman R; Papassotiriou J; Morgenthaler NG; Meisner M; Teixeira PJ
    Intensive Care Med; 2008 Nov; 34(11):2084-91. PubMed ID: 18523752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mid-regional pro atrial natriuretic peptide allows the accurate identification of patients with atrial fibrillation of short time of onset: a pilot study.
    Meune C; Vermillet A; Wahbi K; Guerin S; Aelion H; Weber S; Chenevier-Gobeaux C
    Clin Biochem; 2011 Nov; 44(16):1315-9. PubMed ID: 21871875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive Lifestyle Intervention Increases Plasma Midregional Proatrial Natriuretic Peptide Concentrations in Overweight Children.
    Thomsen CF; Goharian TS; Larsen KT; Goetze JP; Andersen LB; Jeppesen JL
    J Am Heart Assoc; 2021 Jul; 10(13):e020676. PubMed ID: 34180245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic merit of N-terminal-proBNP and N-terminal-proANP in mechanically ventilated critically ill patients.
    Berdal JE; Stavem K; Omland T; Hall C; Smith-Erichssen N
    Acta Anaesthesiol Scand; 2008 Oct; 52(9):1265-72. PubMed ID: 18823467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia.
    Prat C; Lacoma A; Dominguez J; Papassotiriou J; Morgenthaler NG; Andreo F; Tudela P; Ruiz-Manzano J; Ausina V
    J Infect; 2007 Nov; 55(5):400-7. PubMed ID: 17825918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proatrial natriuretic peptide is a better predictor of 28-day mortality in septic shock patients than proendothelin-1.
    Guignant C; Venet F; Voirin N; Poitevin F; Malcus C; Bohé J; Lepape A; Monneret G
    Clin Chem Lab Med; 2010 Dec; 48(12):1813-20. PubMed ID: 20704539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP.
    Boeck L; Eggimann P; Smyrnios N; Pargger H; Thakkar N; Siegemund M; Marsch S; Rakic J; Tamm M; Stolz D
    Eur Respir J; 2011 Mar; 37(3):595-603. PubMed ID: 20530040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The midregional fragment of pro-A-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25).
    van Hateren KJ; Landman GW; Kleefstra N; Groenier KH; Struck J; Navis GJ; Bakker SJ; Houweling ST; van der Meer K; Bilo HJ
    Diabetes Care; 2013 May; 36(5):1347-52. PubMed ID: 23230100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.